Talk:2011 Group Project 2: Difference between revisions

From Embryology
No edit summary
No edit summary
Line 10: Line 10:


--[[User:Z3288729|Sarah Jenkins]] 10:00, 6 August 2011 (EST)
--[[User:Z3288729|Sarah Jenkins]] 10:00, 6 August 2011 (EST)
'''Primary''' http://www.ncbi.nlm.nih.gov/pubmed/15991868 Diagnosis and management of Duchenne muscular dystrophy in a developing country over a 10-year period.
'''Review''' http://www.ncbi.nlm.nih.gov/pubmed/14526374 Advances in Duchenne muscular dystrophy gene therapy.
--Anna Marx 12:52, 8 August 2011 (EST)




==Reference List==
==Reference List==
<references/>
<references/>

Revision as of 12:52, 8 August 2011

Group 2: User:z3279511 | User:z3288196 | User:z3288729 | User:z3288827

Plagiarism

--Mark Hill 07:35, 30 September 2011 (EST) Currently all students originally assigned to each group are listed as equal authors/contributors to their project. If you have not contributed the content you had originally agreed to, nor participated in the group work process, then you should contact the course coordinator immediately and either discuss your contribution or request removal from the group author list. Remember that all student online contributions are recorded by date, time and the actual contributed content. A similar email reminder will be sent to all current students.

Please note the Universities Policy regarding Plagiarism

In particular this example:

"Claiming credit for a proportion of work contributed to a group assessment item that is greater than that actually contributed;"

Academic Misconduct carries penalties. If a student is found guilty of academic misconduct, the penalties include warnings, remedial educative action, being failed in an assignment or excluded from the University for two years.

2011 Projects: Turner Syndrome | DiGeorge Syndrome | Klinefelter's Syndrome | Huntington's Disease | Fragile X Syndrome | Tetralogy of Fallot | Angelman Syndrome | Friedreich's Ataxia | Williams-Beuren Syndrome | Duchenne Muscular Dystrolphy | Cleft Palate and Lip


Week 3 references

Review Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications.

Primary Detection of duchenne/becker muscular dystrophy carriers in a group of Iranian families by linkage analysis.

--Sarah Jenkins 10:00, 6 August 2011 (EST)

Primary http://www.ncbi.nlm.nih.gov/pubmed/15991868 Diagnosis and management of Duchenne muscular dystrophy in a developing country over a 10-year period.

Review http://www.ncbi.nlm.nih.gov/pubmed/14526374 Advances in Duchenne muscular dystrophy gene therapy.

--Anna Marx 12:52, 8 August 2011 (EST)


Reference List